Channel Therapeutics Corporation - CHRO

SEC Filings Our CHRO Tweets

About Gravity Analytica

Recent News

  • 07.31.2026 - A Personalized Customer Experience: How to Use Data Responsibly
  • 07.24.2026 - Data Lineage: The Missing Link to Your Data Strategy
  • 07.07.2026 - Customer Data Debt: How to Solve this Growing Concern
  • 07.03.2026 - Identity-Based Marketing: The Secret Sauce to Results
  • 06.26.2026 - Audience Curation Vs. Audience Resolution: Understanding the Differences
  • 06.24.2026 - VisitIQ Appoints Conner Roos as Chief Financial Officer
  • 06.09.2026 - Six Steps to a Successful Data Activation Strategy
  • 06.05.2026 - Understanding the Differences Between First-Party Data, Second-Party Data and Third-Party Data
  • 03.27.2026 - Upcoming Webcast: Using AI Insights to Optimize Campaign Performance
  • 11.04.2025 - Pete Blackhurst, International SaaS Revenue Leader, Joins VisitIQ™ as Chief Revenue Officer

Recent Filings

  • 07.07.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.07.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.07.2026 - 4 Statement of changes in beneficial ownership of securities
  • 06.17.2026 - 4 Statement of changes in beneficial ownership of securities
  • 06.15.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.28.2026 - 8-K Current report
  • 05.28.2026 - EX-99.1 EX-99.1
  • 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2026 - 144 Report of proposed sale of securities
  • 05.21.2026 - 8-K Current report